Delivery Order 36F79721D0239-36C24526N0725
Award Date 7/10/26
Potential Completion Date 7/15/26
Potential Value $16K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Monroeville, PA 15146, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 5 issued a delivery order to Travere Therapeutics, Inc. on June 24, 2026, for Filspari 400 mg with a ceiling value of $15,866.58, under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is firm fixed price with no set-aside. Place of performance is Monroeville, PA. Ultimate completion date is June 26, 2026. The FSS-61-IB is a multiple-award federal supply schedule for pharmaceutical products under which the VA issues delivery...
- This is a firm fixed-price delivery order award to Travere Therapeutics, Inc., a biopharmaceutical company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21. The contract is for the supply of Travere's specialty pharmaceutical product Filspari 400mg, which is used to treat rare diseases affecting kidney and liver function. The award has a ceiling value of $7,354.26 and a period of performance through September 30, 2024. Travere Therapeutics holds a Federal Supply...
- This federal contract award is a delivery order issued by the Department of Veterans Affairs (VA) to Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies. The contract, valued at $10,888.08, is for the supply of the pharmaceutical drug FILSPARI 200 MG. The contract was awarded through the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), and is a firm fixed-price delivery order with a completion date of June 11, 2025. Travere...
- This is a federal contract award issued by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Travere Therapeutics, Inc. The contract is for the delivery of the pharmaceutical product Filspari, with a ceiling value of $11,280.64 and a completion date of December 18, 2024. The contract is a Delivery Order under Travere's Federal Supply Schedule (FSS) contract with the VA for Pharmaceuticals and Drugs (FSS-61-IB). Additionally, Travere holds two...
- Veterans Integrated Service Network 5 issued a delivery order to Travere Therapeutics, Inc. on April 29, 2026, for $17,667.27 to supply Patient Medication Thiola 100mg for shipment to Clarksburg VA Medical Center's pharmacy. The order is issued under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a multiple-award indefinite delivery vehicle for rare disease pharmaceuticals. Place of performance is San Diego, CA. The ultimate completion date is May 1, 2026. Pricing is firm...
- The Department of Veterans Affairs' Veterans Integrated Service Network 5 (VISN 5) awarded a $28,975.20 delivery order to Travere Therapeutics, Inc. for the supply of Thiola 100 mg, a specialized pharmaceutical used to treat cystinuria and related kidney disorders. This award, issued on November 5, 2025, with an ultimate completion date of November 7, 2025, represents a firm fixed-price delivery order issued under Travere's existing Federal Supply Schedule contract for Pharmaceuticals and...
- Travere Therapeutics, Inc. has been awarded a $11,125.32 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to supply Thiola 100 MG pharmaceutical products. The delivery order was issued under Travere's Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) with no set-aside applied, and performance will occur in San Diego, California by March 12, 2024. Travere specializes in developing therapies for...
- This delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awards Travere Therapeutics, Inc. $10,915.75 to provide Thiola medication for patient use. Issued against the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), this firm fixed price contract has a total small business set aside designation and is to be completed by December 22, 2022. The place of performance is in San Diego, California, where Travere Therapeutics...
- Travere Therapeutics, Inc. was awarded a $18,542.20 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to supply Thioproin pharmaceutical products. The delivery order was issued under Travere's Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) for products to be delivered to the VA medical facility located in San Diego, California by June 2024. No set-aside designation was applied to this...
- Travere Therapeutics, Inc. was awarded a $25,983.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order, which has no set-aside designation, is for the delivery of 100 mg Thiola to the place of performance in San Diego, California. The order has a completion date of March 28, 2023 and was awarded on March 24, 2023 under Master GSA...